Clinical research regulation in India-history, development, initiatives, challenges and controversies: Still long way to go
The Central Drugs Standard Control Organisation and its chairman Drug Controller general of India are bequeathed to protect the citizens from the marketing of unsafe medication. The startling findings, of the 59 th report of the Parliamentary Standing Committee on Health and Family Welfare, have unc...
Main Authors: | Mohammed Imran, Abul K Najmi, Mohammad F Rashid, Shams Tabrez, Mushtaq A Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2013-01-01
|
Series: | Journal of Pharmacy and Bioallied Sciences |
Subjects: | |
Online Access: | http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2013;volume=5;issue=1;spage=2;epage=9;aulast=Imran |
Similar Items
-
Drugs approved by CDSCO, India in 2015
by: K Parushuram Naik1 , V Sai Lakshmi2 , J Jyothirmai3
Published: (2016-04-01) -
Drug labeling: The study of compliance of regulatory requirements for prescription drugs in India
by: Suchi Shah, et al.
Published: (2020-01-01) -
Indian regulatory update April–October 2018
by: Amita Bhave, et al.
Published: (2019-01-01) -
An investigation into the effect of particulate solids on certain antimicrobial preservatives in pharmaceutical and cosmetic suspensions
by: Horn, Norman Robert
Published: (1978) -
Correcting India’s Chronic Shortage of Drug Inspectors to Ensure the Production and Distribution of Safe, High-Quality Medicines
by: Abhay B. Kadam, et al.
Published: (2016-09-01)